We provide evidence that TRPC5 is protective in a murine model of arthritis, where genetic deletion/pharmacological blockade of TRPC5 sustained active joint inflammation, augmented hyperalgesia and synovitis. Here, TRPC5 is linked to arthritic joint disease.